se of ketofol (ketamine pluse propofol) in modified ECT as compair to propofol alone in modified ECT in terms of seizure duration, haemodynamic stability and adverse events if any.
Not Applicable
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/04/032916
- Lead Sponsor
- JLN medical college ajmer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. Age 18 to 60 years of either sex undergoing modified ECT.
2. ASA I and II grades.
3. Modified ECT under general anaesthesia.
4. Informed written consent.
Exclusion Criteria
1. History of any serious physical disease, such as cardiovascular disease, cerebrovascular disorder, intracranial hypertension, respiratory tract disease, and severe fracture.
2. Hypertension, glaucoma, arterial aneurysm, or cerebrovascular malformation.
3. Presence of a foreign body, such as a pacemaker, intracranial electrode, and clips.
4. History of seizures and those using anticonvulsant drugs.
5. History of substance abuse or dependence, including alcohol abuse.
6. ASA III,IV,V status.
7. Hypersensitivity to any study drug.
8. Pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of our study will be to assess duration of seizure activity (from the time of administration of electrical stimuli to the time of end of seizure in isolated arm).Timepoint: Duration of study is around 1 year
- Secondary Outcome Measures
Name Time Method Secondary outcome will be assessment of Hemodynamic changes, recovery parameters, adverse events, if any in modified ECT. <br/ ><br>Timepoint: Duration of study is around 1 year